Sai Parenterals subsidiary wins AUD 202M OTC supply deal in Australia

Order Above 5pct RevenueExport Order Hard CurrencyBusiness Updates View source PDF

SAIPARENT · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+0.4%1-day move

₹617.95

prior close

₹676.15

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-4.2-4.5-6.0-5.3+0.4-1.3-3.2-4.4-3.9-5.0-13.1———

Up moveDown movePending

AI summary

Sai Parenterals' subsidiary Noumed Pharmaceuticals Pty Ltd has signed an exclusive OTC medicines supply agreement with Australia's leading pharmacy network. The contract is valued at AUD 202 million (around INR 1,300 crores) for 7.5 years, with an option to extend by 3 years. Effective from 1 July 2026. No promoter or related party interest is involved in the deal.

Likely market impact

Major multi-year export contract worth about INR 1,300 crores strengthens revenue visibility and international presence.